Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

German CLL Study Group

The importance of treatment sequencing in CLL 1:29
The importance of treatment sequencing in CLL
Barbara Eichhorst • 7 Oct 2022
Updates from the German CLL Study Group 3:53
Updates from the German CLL Study Group
Michael Hallek • 28 Aug 2020
Inside the German CLL Study Group’s annual workshop 1:20
Inside the German CLL Study Group’s annual workshop
Barbara Eichhorst • 9 Jun 2016
The 2016 International Workshop of the German CLL Study Group (GCLLSG) 1:08
The 2016 International Workshop of the German CLL Study Group (GCLLSG)
Michael Hallek • 9 Jun 2016
What is the role of allogeneic stem cell transplantation in CLL in the light of novel drugs? 2:24
What is the role of allogeneic stem cell transplantation in CLL in the light of novel drugs?
John Gribben • 17 Sep 2016
How combining an evolutionary perspective with genomic methods can advance CLL treatment 4:54
How combining an evolutionary perspective with genomic methods can advance CLL treatment
Dan Landau • 17 Sep 2016
GCLLSG trial results to be presented at the 2016 ASH Annual Meeting 1:25
GCLLSG trial results to be presented at the 2016 ASH Annual Meeting
Barbara Eichhorst • 16 Sep 2016
CLL2-GIVe trial: investigating chemotherapy-free treatment of CLL 1:11
CLL2-GIVe trial: investigating chemotherapy-free treatment of CLL
Stephan Stilgenbauer • 17 Sep 2016
Highlights from the International Workshop of the German CLL Study Group 3:11
Highlights from the International Workshop of the German CLL Study Group
Michael Hallek • 17 Sep 2016
How to overcome resistance to new compounds in CLL 2:41
How to overcome resistance to new compounds in CLL
Arnon Kater • 17 Sep 2016
How to treat a previously treated CLL patient 2:16
How to treat a previously treated CLL patient
Carsten Niemann • 16 Sep 2016
An overview of iwCLL 2017 meeting in New York by Prof. Michael Hallek 1:33
An overview of iwCLL 2017 meeting in New York by Prof. Michael Hallek
Michael Hallek • 16 Sep 2016
The importance of the life cycle of CLL cells and how it can inform treatment 3:28
The importance of the life cycle of CLL cells and how it can inform treatment
Nicholas Chiorazzi • 16 Sep 2016
iwCLL 2017 program: the biology of CLL, treatment options and the relapsed/refractory setting 2:50
iwCLL 2017 program: the biology of CLL, treatment options and the relapsed/refractory setting
Nicholas Chiorazzi • 16 Sep 2016
Changes in research to overcome the problem of resistance to new CLL drugs 1:10
Changes in research to overcome the problem of resistance to new CLL drugs
Arnon Kater • 16 Sep 2016
The discovery and role of BCL2 and microRNA in CLL 4:04
The discovery and role of BCL2 and microRNA in CLL
Carlo Croce • 16 Sep 2016

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter

Subscribe now
The content of VJHemOnc is intended for healthcare professionals